Euroasian journal of hepato-gastroenterology

Register      Login

VOLUME 1 , ISSUE 2 ( July-December, 2011 ) > List of Articles


Prevalence of Transfusion Transmitted Infection in Healthy Blood Donors in Sir Salimullah Medical College Dhaka, Bangladesh

Shasanka Kumar Saha, Ranjit Kumar Banik, Mili Rani Saha, Munshi M Habibullah

Citation Information : Kumar Saha S, Kumar Banik R, Rani Saha M, M Habibullah M. Prevalence of Transfusion Transmitted Infection in Healthy Blood Donors in Sir Salimullah Medical College Dhaka, Bangladesh. Euroasian J Hepatogastroenterol 2011; 1 (2):68-70.

DOI: 10.5005/jp-journals-10018-1015

License: CC BY-NC 4.0

Published Online: 01-01-2011

Copyright Statement:  Copyright © 2011; The Author(s).


Background: Transfusion of blood and blood components, as a specialized modality of patient management, saves millions of lives worldwide each year and reduce morbidity. It is well-known that blood transfusion is associated with a large number of complications. Objective: The objective of the present study was to assess the status of transfusion transmitted infections (TTI) among the apparently healthy donors so as to increase the awareness of complications of blood transfusion and make the clinicians more vigilant with regard to judicious use of blood. Methods: A total of 21,966 units of donor’s blood were screened from January 2007 to December 2010 at blood bank of Sir Salimullah Medical College, Mitford Hospital, Dhaka. All the samples were screened for hepatitis B surface antigen (HBsAg), hepatitis C virus (HCV), human immunodeficiency virus (HIV) 1 and 2, venereal disease research laboratory test (VDRL) and malaria. All healthy blood donors were 18 to 60 years old. Result: Prevalence of hepatitis B virus (HBV), HCV, HIV and syphilis were 2.19, 0.25, 0.06 and 0.15% respectively. No blood donor tested showed positivity for malarial parasite. With the implementation of strict donor selection criteria and use of sensitive screening test, it may be possible to reduce the incidence of TTI in the Bangladeshi population.

PDF Share
  1. Glynn SA, Kleinman SH, Wright DJ, Busch MP. International application of the incidence rate and window-period model (editorial). National heart, lung and blood institute retrovirus epidemiology donor study. Transfusion 2002;42:966-73
  2. Current prevalence and incidence of infectious disease markers and estimated windowperiod risk in the American Red Cross Blood Donor population. Transfusion 2002;42:975-79
  3. Will blood transfusion ever be safe enough? JAMA 2000;284:238-40
  4. Nucleic acid amplification testing of blood donations. In: Sibinger S, Klein HG (Eds). Molecular biology in blood transfusion (1st ed). Netherlands: Kluwer Academic Publications 2000;81-103
  5. Emerging infections in transfusion medicine. Clin Lab Med 2004;24:797-823
  6. Estimated risk of transfusion-transmitted viral infections in Spain. Transfusion 2002;42:994-98
  7. NHLBIREDS NAT study group: A new strategy for estimating risks of transfusiontransmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005;45:254-64
  8. Risks of transfusion-transmitted infections. Curr Opin Hematol 2003;10:412-18
  9. For the NHLBI retrovirus epidemiology donor study: International application of the incidence rate/window-period model. Transfusion 2002;42:966-72
  10. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors. The National Medical Journal of India 2004;171:19-21
  11. Relative prevalence of hepatitis B viral markers and hepatitis C virus antibodies (anti-HCV) in Madurai, South India. Indian Journal of Medical Sciences 2000;547:270-73
  12. How safe are our safe donors? Indian Journal of Pathology and Microbiology 1999;424:411-16
  13. Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in Western India. Indian Journal of Pathology and Microbiology 2001;444:409-12
  14. Effectiveness of mandatory transmissible diseases screening in Indian blood donors. Indian Journal of Medical Research 1995;101:229-32
  15. Prevalence of hepatitis B carrier and HIV in healthy blood donors at Ayub Teaching Hospital, Pakistan. J Med Res 2000;39:91-92
  16. Prevalence of HBV, HCV and HIV in blood donors at Liaquatpur. Professional Med J 2006;13:23-26
  17. Prevalence of HIV in blood donors in NWFP. J Postgrad Med Inst 2002;16:187-89
  18. Prevalence of Hepatitis B, C and HIV infection in blood donors of Multan region. Ann King Edward Med Coll 2004;10:459-61
  19. Prevalence of hepatitis B surface antigen and anti-hepatitis C virus. Professional Med J 2004:11(3):334-37
  20. The past incidence of hepatitis C virus infection; implication for the future burden of chronic liver disease in United States. Hematol 2000;31:777-82
  21. Seroprevalence of HIV, HBV, HCV and syphilis in voluntary blood donors. Indian Journal of Medical Sciences 2004;58:255-57
  22. Prevalence of hepatitis C antibodies in healthy blood donors at services Hospital Lainore, Pakistan. Postgrad Med J 2002;13:18-20
  23. Prevalence of anti-hepatitis C antibodies and hepatitis B surface antigen in healthy blood bonors in Bastan Pak Armed Forces. Med J 2006;56(2):189-91
  24. Transfusion-transmitted infections: Existing and emerging pathogens. Journal of Post Graduate Medicine 2005;51:146-51
  25. Serological findings amongst first-time blood bonors in Yaounoe, Cameroon is safe bonotion a reality or a myth. Transfusion Medicine 2003;13: 267-73
  26. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar Es Salaam. Tanzania BMC Public Heath 2006;6:21.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.